NOVAN Nitric Oxide-Based Medicine
We use our proprietary nitric oxide-based science and technology platform to develop innovative, first-in-class therapies for unmet medical needs.
Press Releases
-
September 24, 2020
Novan Strengthens Financial Leadership with Appointments of Chief Financial Officer and Seasoned Industry Executive to Board of Directors
-
September 14, 2020
Novan Provides Pipeline and Priority Development Programs Update
-
September 9, 2020
Novan to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
